2,2'-azobis(2-amidinopropane) has been researched along with Leukemia, Erythroblastic, Acute in 1 studies
2,2'-azobis(2-amidinopropane): water-soluble free-radical initiator
Leukemia, Erythroblastic, Acute: A myeloproliferative disorder characterized by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kulkarni, AP | 1 |
| Mittal, SP | 1 |
| Devasagayam, TP | 1 |
| Pal, JK | 1 |
1 other study available for 2,2'-azobis(2-amidinopropane) and Leukemia, Erythroblastic, Acute
| Article | Year |
|---|---|
Oxidative stress perturbs cell proliferation in human K562 cells by modulating protein synthesis and cell cycle.
Topics: Amidines; Apoptosis; Cell Cycle; Cell Growth Processes; Cell Survival; Humans; Hydrogen Peroxide; K5 | 2009 |